Background: Diagnosis of cough variant asthma is very important. Objectives: The purpose of the present study was to measure the diagnostic value of eosinophil counts in sputum for the diagnosis of cough variant asthma patients. Methodology: This descriptive type of cross-sectional study was carried out in the
Introduction
Patients with cough variant asthma (CVA) are usually presented with a chronic cough which is the sole symptom 1 . It responds to bronchodilator treatment and show airway hyperresponsiveness 2 . Cough variant asthma is one of the most common causes of chronic cough 2 . It has been considered a precursor 3 and a variant form of classic asthma with typical symptoms of wheezing and dyspnea 4 . Several studies have examined mechanistic differences between CVA and classic asthma [5] [6] [7] .
People with cough-variant asthma often have no other "classic" asthma symptoms, such as wheezing or shortness of breath 8 . CVA is somewhat difficult to diagnose because the cough may be the only symptom, with normal physical examination, chest X-rays, and spirometry. There are three recommended ways to diagnose the cough variant asthma of variability in lung function or of air way hyper-responsiveness and search for sputum eosinophils 9 . Positive methacholine challenge test will indicate asthma; however, methacholine test is also positive in a wide variety of other diseases. This test also causes a false negative response. Methacholine challenge testing is more useful in excluding a diagnosis of asthma than in establishing one because its negative predictive power is greater than its positive predictive power 10 . Therefore, the present study was undertaken to measure the diagnostic value of eosinophil counts in sputum for the diagnosis of cough variant asthma patients.
Methodology
This descriptive type of cross-sectional study was carried out in the Department of Respiratory Medicine at National Institute of Diseases of the Chest and Hospital (NIDCH), Dhaka, Bangladesh from September 2014 to August 2015 for a period of one year. Sputum examination was performed in the Microbiology Department of National Institute of Diseases of the Chest and Hospital, Dhaka, Bangladesh. Purposive sampling technique was used to select the patients. Patients with the age of more than or equal to 30 years who were suffering from chronic cough for more than 8 weeks with positive methacholine challenge test were included as study population. Smokers, patients having COPD, patients having other causes of chronic cough like post nasal drip, gastro-esophageal reflux disease, ILD, heart failure, use of ACE inhibitor drugs were excluded from this study. In the first phase a standard questionnaire was designed with a view to collect data. Informed written consent was taken from each patient. Initial evaluation of the patient by history and clinical examination was performed and recorded in the preformed data sheet. Subjects were explained the procedure. Baseline spirometry was performed before methacholine used. Prepared 10 doubling concentrations of methacholine were followed 0. Methacholine challenge test was performed 1 . Concentration of methacholine was started from minimum concentration 0.03 mg/dL and was gradually increased the dose up to the level at which 20.0% fall in FEV 1 was observed from base line or the highest concentration (16 mg/dL) of the drug had been delivered. A total of 10 doses were given if the entire procedure was finished without a positive response. Another spirometry was performed and result was recorded. Patients were resuscitated by nebulised bronchodilator. The procedure was performed in the respiratory laboratory of NIDCH, Dhaka. During sputum assays, the volume was assessed by the size and number of plugs: a cumulative size of 4.5x 9 mm was estimated to be necessary to perform all investigation. Differential counts were determined by counting 200 non-squamous cells on each sputum slide. Statistical analyses were carried out by using the Statistical Package for Social Sciences version 16.0 for Windows (SPSS Inc., Chicago, Illinois, USA). Continuous variables were expressed as mean, standard deviation, and categorical variables as frequencies and percentages.
Results
A total 50 patients were included in the study. Majority (44.0%) patients were in the age group of 21 to 30 years followed by the age group of 11 to 20 years (38.0%). The mean age was found 19.1±7.6 years with range from 8 to 30 years (Table  1) . More than 11000/cumm was counted as leucocytosis. In this study leucocytosis was found in 10(20.0%) cases and the rest 40(80.0%) was presented without any leucocutosis (Table 2) . In this study more than 6.0% eosinophil count in blood was designated as eosinophilia. Therefore, eosinophilia was found in 16(32.0%) cases and the rest 34(68.0%) cases were normal eosinophil count (Table 3) . It was observed that majority 28(56.0%) patients had normal total circulating eosinophil (<400/cmm) and 22(44.0%) had increased (>400/cmm) total circulating eosinophil ( Figure I ).
Figure I: Total Circulating Eosinophil in the Study Patients
In this study all (100.0%) patients had negative CFT for filarial (Table 4 ). Table 5 showed that all (100.0%) patients had increased serum IgE level (Table 5 ). Figure II) .
.
Figure II: Pie chart showing Sputum Eosinophil in the Study Patients
In this study more than 3% eosinophil count in sputum was found in 45(90.0%) patients and 5(10.0%) patients had less than or equal to 3% eosinophil count in sputum (Table 6 ). . Coughing is more frequent during methacholine-induced bronchoconstriction in the CVA group, whereas wheezes is more frequent in the classic asthma group at the end of methacholine inhalation 12 .
This present observational study has been carried out with an aim to find out the easy technique for diagnosis of cough variant asthma and to determine the eosinophil count in patients with cough variant asthma. A total of 50 patients are enrolled in this 
Sputum eosinophil
Positive Negative study. In this study it has been observed that 42.0% patients belong to age 21 to 30 years and the mean age is 19.1±7.6 years with range from 8 to 30 years. Yoo et al 13 have showed that the mean (±SD) age is 11.4±2.2 years, which is lesser with the present study. On the other hand Al-Moamary et al 14 have found that the mean age is 32.05±10.87 years. The high mean age and age range has been obtained may be due to geographical variation as well as racial influences.
In this study 10(20.0%) patients had increased leucocyte count. Matsuoka et al 15 showed a total leukocyte count of 8200 cells /mm 3 with 65.4% neutrophils and 3.0% eosinophils. In this series it was observed that nearly one third (32.0%) patients had Eosinophilia. Harish and Suryanarayana 16 observed 61% had eosinophilia and 39.0% had normal counts. In this present study 56.0% patients had normal total circulating eosinophil and 44.0% had increased total circulating eosinophil. Increased eosinophil counts have also been reported in a large proportion of patients with asthma treated with inhaled corticosteroids observed by Richter et al 17 .
In this present study it has been observed that all (100.0%) patients have negative CFT for filaria and all (100.0%) patients have increased serum IgE level. Surprisingly, a correlation with total serum IgE has been demonstrated in a study by Good et al 18 in which bronchoscopy has been used to assess asthma phenotypes. Therefore, total serum IgE is not useful as a diagnostic marker for eosinophilic asthma. In this present study it was observed that 96.0% patients had sputum Eosinophil. Harish and Suryanarayana 16 obtained in their study that 87.5% subjects had sputum eosinophilia. In this current study, study patients is divided into two category on the basis of the eosinophil count in sputum as follows, sputum eosinophil count >3%, and ≤ 3% category, it was observed that 90.0% populations had sputum eosinophil count >3% and 10% had ≤ 3% sputum eosinophil count. Alvarez et al 6 have reported that an increase of eosinophil count (>3.2%) in induced sputum has been observed in three out of six patients with chronic cough and bronchial hyperresponsiveness, who might be given a diagnosis of CVA 5 . Ayik et al 2 mentioned that sputum eosinophilia greater than 3.0% is present in 33.3% patients and the patients have been diagnosed as eosinophilic bronchitis. Niimi et al 3 showed 5 out of 6 patients a marked increase of eosinophils in sputum more than 80% of the nucleated cells. Godon et al 4 studies have revealed that more than 50.0% of asthmatic patients who received no anti-inflammatory treatment have an increased induced sputum eosinophil count. All this studies revealed that asthmatic patients have higher sputum eosinophil count.
Conclusion
In conclusion sputum eosinophil count becomes elevated in cough variant asthma (CVA). In majority of the cases, sputum eosinophil count is more than 3%. In presence of appropriate background like unproductive cough for more than 8 weeks, and exclusion of other causes, sputum eosinophil count more than 3% may be considered for the diagnosis of CVA.
